SynthesisEuropean journal of medical research2025

The efficacy and safety of efgartigimod for refractory myasthenia gravis: a systematic review and meta-analysis.

Jia-Jun Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.